We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

222 hedge funds and large institutions have $3.53B invested in SpringWorks Therapeutics in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

839% more call options, than puts

Call options by funds: $465M | Put options by funds: $49.6M

100% more funds holding in top 10

Funds holding in top 10: 9 → 18 (+9)

20% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 69

7% more capital invested

Capital invested by funds: $3.29B → $3.53B (+$235M)

0.13% more ownership

Funds ownership: 99.46% → 99.59% (+0.13%)

27% less funds holding

Funds holding: 306 → 222 (-84)

61% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 132

Holders
222
Holders Change
-84
Holders Change %
-27.45%
% of All Funds
2.92%
Holding in Top 10
18
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+100%
% of All Funds
0.24%
New
51
Increased
83
Reduced
69
Closed
132
Calls
$465M
Puts
$49.6M
Net Calls
+$416M
Net Calls Change
+$248M

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$183M
2
Fidelity International
Fidelity International
Bermuda
+$134M
3
TAL
TIG Advisors LLC
New York
+$105M
4
BCM
Beryl Capital Management
California
+$94.2M
5
MF
Magnetar Financial
Illinois
+$91.3M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$498M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$112M
3
PCH
Polar Capital Holdings
United Kingdom
-$77.2M
4
WP
Woodline Partners
California
-$76M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$73.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
301
SG Americas Securities
New York
– -$672K -15,235 Closed
CUAMC
302
China Universal Asset Management Company
China
– -$663K -15,031 Closed
Jennison Associates
303
Jennison Associates
New York
– -$652K -14,782 Closed
PAP
304
Persistent Asset Partners
Hong Kong
– -$610K -13,819 Closed
OAM
305
Oppenheimer Asset Management
New York
– -$597K -13,526 Closed
IC
306
Ikarian Capital
Texas
– -$552K -12,519 Closed
CT
307
ClearAlpha Technologies
Connecticut
– -$530K -12,000 Closed
CF
308
Cantor Fitzgerald
New York
– -$523K -11,841 Closed
Allianz Asset Management
309
Allianz Asset Management
Germany
– -$521K -11,800 Closed
SMH
310
Sanders Morris Harris
Texas
– -$469K -11,200 Closed
SCA
311
Snowden Capital Advisors
New York
– -$491K -11,115 Closed
CCIA
312
Campbell & Co Investment Adviser
Maryland
– -$482K -10,918 Closed
C
313
Covestor
United Kingdom
– -$471K -10,587 -100%
FIA
314
FNY Investment Advisers
New York
– -$470K -10,575 Closed
DnB Asset Management
315
DnB Asset Management
Norway
– -$461K -10,444 Closed
NRD
316
Nebula Research & Development
New York
– -$458K -10,385 Closed
VIA
317
Virtus Investment Advisers
Connecticut
– -$409K -9,279 Closed
Mariner
318
Mariner
Kansas
– -$408K -9,241 Closed
DFCM
319
Dark Forest Capital Management
Puerto Rico
– -$407K -9,222 Closed
BAM
320
Blueshift Asset Management
New Jersey
– -$401K -9,096 Closed
GCP
321
GSA Capital Partners
United Kingdom
– -$378K -8,560 Closed
BC
322
Birchview Capital
Vermont
– -$365K -8,280 Closed
YIH
323
Y-Intercept (HK)
Hong Kong
– -$356K -8,058 Closed
BAM
324
Bosun Asset Management
Illinois
– -$349K -7,912 Closed
FC
325
FORA Capital
Florida
– -$343K -7,775 Closed
11 12
13
14 15

SWTX Hedge Fund Activity: Q2 2025 in Review

222 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q2 2025, worth a combined $3.53B — up 7.1% from $3.29B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of SWTX and 51 opened new positions — a net loss of 81 holders — while 69 trimmed existing stakes and 83 added.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $183M. The largest seller was Fidelity Investments, cutting an estimated $498M.

  • 222 institutional investors held SpringWorks Therapeutics (SWTX) as of Q2 2025, down from 306 in Q1 2025.
  • Funds reported $3.53B of SpringWorks Therapeutics stock for Q2 2025, up 7.1% quarter-over-quarter.
  • 51 funds opened new SpringWorks Therapeutics positions in Q2 2025 and 132 closed out, a net change of -81 holders.
  • The largest SpringWorks Therapeutics buyer in Q2 2025 was Glazer Capital LLC, an estimated $183M added.
  • The largest SpringWorks Therapeutics seller in Q2 2025 was Fidelity Investments, an estimated $498M sold.

Based on aggregated 13F filings for Q2 2025.